These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16837277)

  • 1. Apo E polymorphism and the removal of remnants of triglyceride-rich lipoproteins in normolipidemic subjects during a carbohydrate-rich diet.
    Brenninkmeijer BJ; Stuyt PM; Demacker PN; Stalenhoef AF; van't Laar A
    Clin Nutr; 1989 Jun; 8(3):127-33. PubMed ID: 16837277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype.
    Brenninkmeijer BJ; Stuyt PM; Demacker PN; Stalenhoef AF; van 't Laar A
    J Lipid Res; 1987 Apr; 28(4):361-70. PubMed ID: 3585171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state.
    Smith D; Watts GF; Dane-Stewart C; Mamo JC
    Eur J Clin Invest; 1999 Mar; 29(3):204-9. PubMed ID: 10202376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationship of triglycerides with lipoproteins and high-density lipoproteins.
    Gotto AM
    Am J Cardiol; 1990 Sep; 66(6):20A-23A. PubMed ID: 2203246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.
    Karpe F; Bell M; Björkegren J; Hamsten A
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):199-207. PubMed ID: 7749826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal postprandial apolipoprotein B-48 and triglyceride responses in normolipidemic women with greater than 70% stenotic coronary artery disease: a case-control study.
    Meyer E; Westerveld HT; de Ruyter-Meijstek FC; van Greevenbroek MM; Rienks R; van Rijn HJ; Erkelens DW; de Bruin TW
    Atherosclerosis; 1996 Aug; 124(2):221-35. PubMed ID: 8830935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.
    Bersot TP; Innerarity TL; Pitas RE; Rall SC; Weisgraber KH; Mahley RW
    J Clin Invest; 1986 Feb; 77(2):622-30. PubMed ID: 2935560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of remnant particles by immunoseparation: a new approach for investigation of postprandial lipoprotein metabolism in normolipidemic subjects.
    Schreuder PC; Twickler TB; Wang T; Nakajima K; Erkelens DW; Dallinga-Thie GM
    Atherosclerosis; 2001 Jul; 157(1):145-50. PubMed ID: 11427214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slower catabolism of apo B48 than of apo B100 in triglyceride-rich lipoproteins during heparin infusions in type 5 hyperlipoproteinemic subjects.
    Nestel P; Billington T
    Metabolism; 1987 Feb; 36(2):172-5. PubMed ID: 3807788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-VLDL accumulation in familial dysbetalipoproteinemia is associated with increased exchange or diffusion of chylomicron lipids to apo B-100 containing triglyceride-rich lipoproteins.
    Demacker PN; Bredie SJ; Vogelaar JM; Hectors MP; van Heijst P; Stuyt PM; Stalenhoef AF
    Atherosclerosis; 1998 Jun; 138(2):301-12. PubMed ID: 9690913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
    Hazzard WR; Bierman EL
    Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects.
    Berr F; Kern F
    J Lipid Res; 1984 Aug; 25(8):805-12. PubMed ID: 6491526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiology and pathophysiology of the metabolism of lipoproteins].
    Sandhofer F
    Wien Med Wochenschr; 1994; 144(12-13):286-90. PubMed ID: 8650930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
    Björkegren J; Silveira A; Boquist S; Tang R; Karpe F; Bond MG; de Faire U; Hamsten A
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1470-4. PubMed ID: 12231568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E enrichment of immuno-separated chylomicron and chylomicron remnants following saturated fatty acids.
    Jackson KG; Wolstencroft EJ; Bateman PA; Yaqoob P; Williams CM
    Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):405-17. PubMed ID: 16935699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
    Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV
    J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.
    Cabezas MC; de Bruin TW; Kock LA; Kortlandt W; Van Linde-Sibenius Trip M; Jansen H; Erkelens DW
    Metabolism; 1993 Apr; 42(4):497-503. PubMed ID: 8487674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe defect in clearing postprandial chylomicron remnants in dialysis patients.
    Weintraub M; Burstein A; Rassin T; Liron M; Ringel Y; Cabili S; Blum M; Peer G; Iaina A
    Kidney Int; 1992 Nov; 42(5):1247-52. PubMed ID: 1453610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.